Preliminary Report of Hiv and Toxoplasma Gondii Occurrence in Pregnant Women From Mozambique
Preliminary Report of Hiv and Toxoplasma Gondii Occurrence in Pregnant Women From Mozambique
Preliminary Report of Hiv and Toxoplasma Gondii Occurrence in Pregnant Women From Mozambique
Sao Paulo
52(6):291-295, November-December, 2010
doi: 10.1590/S0036-46652010000600002
Sonia Paula Benedito Luis SITOE(1), Bernardete RAFAEL(1), Luciana Regina MEIRELES(2), Heitor Franco de ANDRADE JR.(2) & Ricardo THOMPSON (1)
SUMMARY
Toxoplasmosis, a protozoan disease, causes severe disease in fetuses during pregnancy and deadly encephalitis in HIV patients.
There are several studies on its seroprevalence around the world, but studies focusing on African countries are limited in number and
mostly anecdotal. We studied two groups of samples from Mozambique by ELISA, using serum samples from 150 pregnant women
and six Cerebrospinal fluid (CSF) samples from AIDS patients with encephalitis. HIV status was confirmed, and CD4 blood counts
were obtained from HIV-positive pregnant women. IgG seroprevalence of the group as a whole was 18.7% (28/150), with a higher
prevalence in HIV-positive individuals compared to those who were HIV-negative (31.3%, [18/58] vs. 10.9%, [10/92]) patients.
These data may be biased due to cumulative effects of exposition affecting disease prevalence. If corrected, this data may indicate
an interaction of HIV and T. gondii. Prevalence of both diseases increases with age, but this is more clearly seen for toxoplasmosis
(p < 0.005) than HIV infection, possibly explained by higher transmission of HIV after childhood. In HIV patients suffering from
encephalitis, CSF serology showed that 33% of specific IgG CSF had a high avidity, which was in accordance with the data from
the group of pregnant women. Lower prevalence rates of both infections in older groups could be explained by more deaths in the
infected groups, resulting in an artificially lower prevalence. Using CD4 counts as a marker of time of HIV infection, and correcting
for age, patients with contact with T. gondii had fewer CD4 cells, suggesting prolonged HIV disease or other causes. Toxoplasma
IgG prevalence is higher in HIV+ groups, which could be ascribed to HIV- and T. gondii-associated risk factors, such as exposure to
higher and more diverse social contacts. The low incidence of Toxoplasma IgG in younger age groups shows that transmission could
be related to better access to cyst-containing meat in adulthood, as environmental transmission due to oocysts is usually blamed for
higher incidence in children. Taken together, these data support the urgent need of research in toxoplasmosis in Africa, especially in
the presence of HIV epidemics.
Cerebrospinal Fluid (CSF) IgG Avidity: The IgG avidity assay was
performed as elsewhere described (MEIRELES et al., 2004) with minor
modifications. ELISA microplates (Multiwell plate/polystyrene, Sigma)
were coated with 100 mL/well of a solution containing 10 mg/mL of the T.
Fig. 1 - Proportion of Toxoplasma-specific antibody detection in sera from pregnant women
gondii antigen extract diluted in 6M urea pH 7.0, incubated overnight at
in Mozambique, in total and sorted according to HIV status, and CSF from encephalitis AIDS
4 °C and blocked for one hour at 37 °C with 2% fat free dry milk. Undiluted
patients. Bars represent 95% confidence interval. In HIV infected women, the odds ratio for
CSF was applied to two wells and incubated for one hour at 37 °C. After toxoplasma infection is 3.6 times higher.
this, one well was washed with 100 mL of 6M urea pH 7.0, and incubated
at 37 °C for 10 min. After the incubation, bound IgG was revealed by The occurrence of both HIV or Toxoplasma infections increases with
specific peroxidase conjugate and o-phenylenediamine. The A492nm was age, as shown in Fig. 2, but this is more clearly seen in toxoplasmosis
determined in the control and urea treated wells by spectrophotometry (p < 0.005) than in HIV infection (p < 0.05), with similar slopes, but
(Multiskan MS). The avidity of each sample was calculated as the percent different intercepts.
of A492nm resistant to urea. Samples with more than 75% A492nm resistance to
urea treatment were considered to have high avidity. Samples with control Looking for interaction between both infections, we sorted the
well values greater than the mean plus three SD of A492nm of negative wells patients according to HIV status to look for occurrence of Toxoplasma-
were considered positive for T. gondii IgG and toxoplasmosis. specific antibody, or according to occurrence of Toxoplasma specific
antibody and frequency of HIV infection in age groups, as shown in
Statistics: Comparisons of frequencies of events between groups Fig. 3. There was a clear increase of Toxoplasma occurrence according
were performed using two-tailed Chi-square tests. Comparisons of to age groups in both HIV-negative (Fig. 3A) and HIV-positive groups
quantitative data, such as CD4+ counts, were performed using Student’s (Fig. 3B), but the curves were quite diverse, due to a difference in age of
t-tests. Age evolution was tested using linear regression and goodness first contact with the agent. The difference in intercepts was significant (p
to fit or r2, with confidence interval comparison between slopes and < 0.004), without a difference in their slopes. Thus, HIV-infected pregnant
intercepts. Differences were considered significant when the probability women appeared to have had contact with T. gondii at lower ages than
of equality was less than 0.05 (p < 0.05). We used for all calculations non-infected women, with a difference of almost 13 years, but after this,
the statistical software Graph Pad Prism 5.0 (GraphPad Software, San the increase of occurrence with age was similar for both groups. After
Diego California USA, www.graphpad.com). sorting by occurrence of Toxoplasma-specific antibody, the occurrence
292
SITOE, S.P.B.L.; RAFAEL, B.; MEIRELES, L.R.; ANDRADE Jr., H.F. & THOMPSON, R. - Preliminary report of HIV and Toxoplasma gondii occurrence in pregnant women from Mozambique.
Rev. Inst. Med. Trop. Sao Paulo, 52(6): 291-5, 2010.
DISCUSSION
Fig. 3 - Occurrence of HIV or toxoplasmosis in age groups, sorted for the other disease serology in pregnant women from Mozambique. A and B: Toxoplasmosis occurrence according to HIV
status A: HIV negative samples, B: HIV positive samples. C and D: HIV occurrence according to toxoplasmosis status C: Toxoplasmosis negative samples, D: Toxoplasmosis positive samples.
Regression was estimated as continuous lines and numbers are expressed as positive/total in each point.
293
SITOE, S.P.B.L.; RAFAEL, B.; MEIRELES, L.R.; ANDRADE Jr., H.F. & THOMPSON, R. - Preliminary report of HIV and Toxoplasma gondii occurrence in pregnant women from Mozambique.
Rev. Inst. Med. Trop. Sao Paulo, 52(6): 291-5, 2010.
294
SITOE, S.P.B.L.; RAFAEL, B.; MEIRELES, L.R.; ANDRADE Jr., H.F. & THOMPSON, R. - Preliminary report of HIV and Toxoplasma gondii occurrence in pregnant women from Mozambique.
Rev. Inst. Med. Trop. Sao Paulo, 52(6): 291-5, 2010.
qualquer causa nos grupos mais idosos, resultando em menor ocorrência 8. Lin DS, Bowman DD. Toxoplasma gondii: an AIDS enhancing cofactor. Med
relativa. Usando as contagens de células CD4+ como marcadores da Hypotheses. 1992;39:140-2.
progressão da infecção pelo HIV e corrigindo para grupos etários, as 9. Lindström I, Kaddu-Mulindwa DH, Kironde F, Lindh J. Prevalence of latent and
gestantes HIV+ com contato com T. gondii tem menores níveis de células reactivated Toxoplasma gondii parasites in HIV-patients from Uganda. Acta Trop.
CD4+ do que as gestantes HIV+ sem contato com T.gondii. A ocorrência 2006;100:218-22.
maior da toxoplasmose em gestantes HIV+ pode ser atribuída a fatores
de risco semelhantes, como exposição a maior contato social. A baixa 10. Makuwa M, Loemba H, Beuzit Y, Livrozet JM, Belec L. Synthèse intrathécale
d’anticorps anti-Toxoplasma gondii au cours de la toxoplasmose cérébrale associée
ocorrência da toxoplasmose em grupos mais jovens pode se relacionar au sida africain. Bull Soc Pathol Exot. 1999;92:95-8.
com menor acesso a carne contendo cistos, já que a transmissão ambiental
por oocistos está associada à maior incidência em crianças. Todos estes 11. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and
dados reforçam a necessidade de pesquisa da toxoplasmose na África prevalence of neurological disorders associated with HIV since the introduction
Austral, especialmente na presença da epidemia pelo HIV. of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry.
2000;69:376-80.
ACKNOWLEDGEMENTS 12. Meireles LR, Galisteo AJ Jr, Pompeu E, Andrade HF Jr. Toxoplasma gondii spreading
in an urban area evaluated by seroprevalence in free-living cats and dogs. Trop Med
This work was supported by Instituto Nacional de Saúde - Ministério Int Health. 2004;9:876-81.
da Saúde-Mozambique, LIMHCFMUSP and CNPq Pró Africa (Proc.
13. Montoya JG, Remington JS. Management of Toxoplasma gondii infection during
No 490374/2008-5). This work is submitted on behalf of S. Sitoe, B. pregnancy. Clin Infect Dis. 2008;47:554-66.
Rafael and R. Thompson, as contact with Maputo authors become very
difficult after August 2009. The corresponding author was responsible for 14. Nabias R, Ngouamizokou A, Migot-Nabias F, Mbou-Moutsimbi RA, Lansoud-Soukate
the analysis and the submission of the article, in consideration that this J. Enquête sérologique sur la toxoplasmose chez les consultants du centre de P.M.I.
work was communicated as an abstract at the 13th International Congress de Franceville (Gabon). Bull Soc Pathol Exot. 1998;91:318-20.
of Protistology, 2009, Búzios, and it was necessary to communicate the 15. Passos LN, Araújo Filho OF, Andrade Junior HF. Toxoplasma encephalitis in AIDS
data in a published paper in a timely fashion. All contacted authors were patients in São Paulo during 1988 and 1991. A comparative retrospective analysis.
in agreement with this arrangement. Rev Inst Med Trop Sao Paulo. 2000;42:141-5.
REFERENCES 16. Purner MB, Berens RL, Tomavo S, Lecordier L, Cesbron-Delauw MF, Kotzin BL, et al.
Stimulation of human T lymphocytes obtained from Toxoplasma gondii-seronegative
persons by proteins derived from T. gondii. J Infect Dis. 1998;177:746-53.
1. Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, Alves CC, Oréfice F, Addiss DG.
Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil.
17. Reithinger R, Kamya MR, Whitty CJ, Dorsey G, Vermund SH. Interaction of malaria
Emerg Infect Dis. 2003;9:55-62.
and HIV in Africa. BMJ. 2009;338:b2141.
2. Becker BJ. Toxoplasmic encephalitis in South Africa; report of two cases. S Afr Med
18. Shimelis T, Tebeje M, Tadesse E, Tegbaru B, Terefe A. Sero-prevalence of latent
J. 1954;28:21-4.
Toxoplasma gondii infection among HIV-infected and HIV-uninfected people in Addis
Ababa, Ethiopia: a comparative cross-sectional study. BMC Res Notes. 2009;2:213.
3. Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United
States. Int J Parasitol. 2008;38:1257-78.
19. Stillwaggon E. Complexity, cofactors, and the failure of AIDS policy in Africa. J Int
AIDS Soc. 2009;12:12.
4. Denkers EY, Butcher BA. Sabotage and exploitation in macrophages parasitized by
intracellular protozoans. Trends Parasitol. 2005;21:35-41.
20. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans.
Int J Parasitol. 2000;30:1217-58.
5. Fasser E. Congenital toxoplasmosis in South Africa; a review and case report. S Afr
Med J. 1955;29:684-8.
21. Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observations. Int J Parasitol.
2009;39:895-901.
6. Flegr J, Zitková S, Kodym P, Frynta D. Induction of changes in human behavior by
the parasitic protozoan Toxoplasma gondii. Parasitology. 1996;113:49-54.
22. Zumla A, Savva D, Wheeler RB, Hira SK, Luo NP, Kaleebu P, et al. Toxoplasma
serology in Zambian and Ugandan patients infected with the human immunodeficiency
7. Hari KR, Modi MR, Mochan AH, Modi G. Reduced risk of toxoplasma encephalitis
virus. Trans R Soc Trop Med Hyg. 1991;85:227-9.
in HIV-infected patients - a prospective study from Gauteng, South Africa. Int J STD
AIDS. 2007;18:555-8.
eceived: 15 June 2010
R
Accepted: 17 September 2010
295